{"url":"https://lda.senate.gov/api/v1/filings/1ac4935f-e6eb-4c0f-97ff-1769c6f55d93/","filing_uuid":"1ac4935f-e6eb-4c0f-97ff-1769c6f55d93","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/1ac4935f-e6eb-4c0f-97ff-1769c6f55d93/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Merola, Managing Partner","dt_posted":"2024-07-23T11:10:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"409 7TH STREET, NW","registrant_address_2":"SUITE 450","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":50796,"url":"https://lda.senate.gov/api/v1/registrants/50796/","house_registrant_id":34724,"name":"WINNING STRATEGIES WASHINGTON","description":"Government relations firm","address_1":"409 7TH STREET, NW","address_2":"SUITE 450","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CARL CHIDLOW","contact_telephone":"+1 202-589-0800","dt_updated":"2026-01-28T09:17:29.205119-05:00"},"client":{"id":60957,"url":"https://lda.senate.gov/api/v1/clients/60957/","client_id":60957,"name":"DBV TECHNOLOGIES","general_description":"Pharmaceutical Company","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-04-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Innovation in medical therapies to treat childhood food allergies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23160,"prefix":null,"prefix_display":null,"first_name":"DONNA","nickname":null,"middle_name":null,"last_name":"MULLINS","suffix":null,"suffix_display":null},"covered_position":"CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa","new":false},{"lobbyist":{"id":43397,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"A","last_name":"MEROLA","suffix":null,"suffix_display":null},"covered_position":"Deputy CoS, Sen. Torricelli","new":false},{"lobbyist":{"id":147435,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"CONNOLLY","suffix":null,"suffix_display":null},"covered_position":"Assistant Director of the Office of Public Health, Office of National Drug Control Policy","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}